Keywords Clear filters View More 3 results for @keyword Filters More search results loaded On the Radar Issue 673 2024 | Newsletter This issue includes items on the new National Safety and Quality Health Service Standards User Guide for the health care of people with intellectual disability, consumer engagement, patient safety, medical research, opioids, medication safety, aged care, infections, and more. Also covered are the latest from BMJ Quality & Safety,... Joint Statement on the Inappropriate Use of Psychotropic Medicines to Manage the Behaviours of People with Disability and Older People 2022 | Corporate On 21 March 2022, the Australian Commission on Safety and Quality in Health Care, the Aged Care Quality and Safety Commission and the NDIS Quality and Safeguards Commission have launched the Joint Statement on the important issue of inappropriate use of psychotropic medicines with people with disability and older people as a form of restrictive... Information for healthcare services – Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard 2024 | Fact sheet This resource accompanies the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard. It describes what the quality statements mean for healthcare services and provides indicators to support local quality improvement activity.